Cargando…
Loss of the Anorexic Response to Systemic 5-Aminoimidazole-4-Carboxamide-1-β-D-Ribofuranoside Administration Despite Reducing Hypothalamic AMP-Activated Protein Kinase Phosphorylation in Insulin-Deficient Rats
This study tested whether chronic systemic administration of 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside (AICAR) could attenuate hyperphagia, reduce lean and fat mass losses, and improve whole-body energy homeostasis in insulin-deficient rats. Male Wistar rats were first rendered diabetic th...
Autores principales: | Vitzel, Kaio F., Bikopoulos, George, Hung, Steven, Curi, Rui, Ceddia, Rolando B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3743807/ https://www.ncbi.nlm.nih.gov/pubmed/23967267 http://dx.doi.org/10.1371/journal.pone.0071944 |
Ejemplares similares
-
Chronic Treatment with the AMP-Kinase Activator AICAR Increases Glycogen Storage and Fatty Acid Oxidation in Skeletal Muscles but Does Not Reduce Hyperglucagonemia and Hyperglycemia in Insulin Deficient Rats
por: Vitzel, Kaio F., et al.
Publicado: (2013) -
Enhancement of insulin-mediated rat muscle glucose uptake and microvascular perfusion by 5-aminoimidazole-4-carboxamide-1-β-d-ribofuranoside
por: Bradley, Eloise A, et al.
Publicado: (2015) -
5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside (AICAR) attenuates the expression of LPS- and Aβ peptide-induced inflammatory mediators in astroglia
por: Ayasolla, Kamesh R, et al.
Publicado: (2005) -
Cytotoxic effect of 5-aminoimidazole-4-carboxamide-1-β-4-ribofuranoside (AICAR) on childhood acute lymphoblastic leukemia (ALL) cells: implication for targeted therapy
por: Sengupta, Tapas K, et al.
Publicado: (2007) -
Cold acclimation reduces hepatic protein Kinase B and AMP‐activated protein kinase phosphorylation and increases gluconeogenesis in Rats
por: Sepa‐Kishi, Diane M., et al.
Publicado: (2018)